CORMEDIX INC. - COMMON STOCK
9,9600
22-ноября-24 15:44:58
15 мин. задержка
Акции
-0,3700
-3,58%
Сегодняшний диапазон
9,9300 - 10,3700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
CorMedix Inc. to Present at the Needham Annual Healthcare Conference
27 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
12 мар 2024 06:30:00 Источник Nasdaq GlobeNewswire
-
06 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial and Reimbursement Updates
30 янв 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Commercial and Operational Updates
08 янв 2024 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Appointment of Chief Legal Officer
15 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Partnership With The Leapfrog Group
04 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
15 ноя 2023 11:57:47 Источник Nasdaq GlobeNewswire
-
14 ноя 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
02 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
11 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
26 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
08 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
06 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
30 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
08 авг 2023 06:30:00 Источник Nasdaq GlobeNewswire
-
26 июл 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
28 июн 2023 21:57:02 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
28 июн 2023 15:07:53 Источник Nasdaq GlobeNewswire
-
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
21 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire